rs459552

Variant summary

Our verdict is . The variant received -17 classification points (ACMG Germline Pathogenicity v2019): 0P and 17B. BA1BP4BP6_Very_Strong

The NM_000038.6(APC):c.5465T>A (p.Val1822Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.781 (AC=1,257,991) in the gnomAD database across 1,611,172 control chromosomes, including 493,662 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.952. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.V1822D: Benign (ClinVar VariationId 3304266, 1 star); p.V1822D: Uncertain_significance (ClinVar VariationId 3343773, 1 star); p.V1822E: Uncertain_significance (ClinVar VariationId 963607, 1 star); p.V1822G: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 231079); p.V1822I: Uncertain_significance (ClinVar VariationId 3411135, 1 star); p.V1822= (synonymous): Likely_benign (ClinVar VariationId 2452708, 1 star); p.V1822= (synonymous): Benign/Likely_benign (ClinVar VariationId 3254437, 2 stars) This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.82 ( 51880 hom., cov: 31)
Exomes 𝑓: 0.78 ( 441782 hom. )

Consequence

APC
NM_000038.6 missense

Scores

1
17

Clinical Significance

Benign reviewed by expert panel B:23O:3

Conservation

PhyloP100: 2.36

Publications

191 publications found
Variant links:
Genes affected
APC (HGNC:583): (APC regulator of WNT signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]
APC Gene-Disease associations (from GenCC):
  • classic or attenuated familial adenomatous polyposis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • desmoid tumor
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • familial adenomatous polyposis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • gastric adenocarcinoma and proximal polyposis of the stomach
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • Cenani-Lenz syndactyly syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000038.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -17 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Supporting).
BP6
ClinVar ≥3 stars benign — very strong (BP6); ClinVar germline classification: Benign/Likely Benign, 3 star(s).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.9524 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000038.6. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APC
NM_000038.6
MANE Select
c.5465T>Ap.Val1822Asp
missense
Exon 16 of 16NP_000029.2
APC
NM_001407446.1
c.5549T>Ap.Val1850Asp
missense
Exon 16 of 16NP_001394375.1
APC
NM_001354896.2
c.5519T>Ap.Val1840Asp
missense
Exon 17 of 17NP_001341825.1R4GMU6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APC
ENST00000257430.9
TSL:5 MANE Select
c.5465T>Ap.Val1822Asp
missense
Exon 16 of 16ENSP00000257430.4P25054-1
APC
ENST00000508376.6
TSL:1
c.5465T>Ap.Val1822Asp
missense
Exon 17 of 17ENSP00000427089.2P25054-1
APC
ENST00000508624.5
TSL:1
n.*4787T>A
3_prime_UTR
Exon 17 of 17ENSP00000424265.1E7EMH9

Frequencies

GnomAD3 genomes
AF:
0.820
AC:
124670
AN:
152042
Hom.:
51821
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.956
Gnomad AMI
AF:
0.782
Gnomad AMR
AF:
0.812
Gnomad ASJ
AF:
0.761
Gnomad EAS
AF:
0.902
Gnomad SAS
AF:
0.793
Gnomad FIN
AF:
0.669
Gnomad MID
AF:
0.813
Gnomad NFE
AF:
0.761
Gnomad OTH
AF:
0.816
GnomAD2 exomes
AF:
0.795
AC:
199083
AN:
250474
AF XY:
0.789
show subpopulations
Gnomad AFR exome
AF:
0.959
Gnomad AMR exome
AF:
0.827
Gnomad ASJ exome
AF:
0.766
Gnomad EAS exome
AF:
0.903
Gnomad FIN exome
AF:
0.688
Gnomad NFE exome
AF:
0.771
Gnomad OTH exome
AF:
0.792
GnomAD4 exome
AF:
0.777
AC:
1133202
AN:
1459012
Hom.:
441782
Cov.:
53
AF XY:
0.776
AC XY:
563110
AN XY:
725998
show subpopulations
African (AFR)
AF:
0.961
AC:
32111
AN:
33408
American (AMR)
AF:
0.827
AC:
36984
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.766
AC:
20005
AN:
26112
East Asian (EAS)
AF:
0.904
AC:
35881
AN:
39672
South Asian (SAS)
AF:
0.779
AC:
67182
AN:
86204
European-Finnish (FIN)
AF:
0.695
AC:
37090
AN:
53394
Middle Eastern (MID)
AF:
0.788
AC:
4543
AN:
5764
European-Non Finnish (NFE)
AF:
0.768
AC:
851815
AN:
1109448
Other (OTH)
AF:
0.789
AC:
47591
AN:
60314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
14897
29794
44692
59589
74486
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20486
40972
61458
81944
102430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.820
AC:
124789
AN:
152160
Hom.:
51880
Cov.:
31
AF XY:
0.816
AC XY:
60692
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.957
AC:
39732
AN:
41534
American (AMR)
AF:
0.812
AC:
12422
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.761
AC:
2640
AN:
3468
East Asian (EAS)
AF:
0.902
AC:
4677
AN:
5184
South Asian (SAS)
AF:
0.793
AC:
3823
AN:
4818
European-Finnish (FIN)
AF:
0.669
AC:
7073
AN:
10572
Middle Eastern (MID)
AF:
0.823
AC:
242
AN:
294
European-Non Finnish (NFE)
AF:
0.761
AC:
51747
AN:
67970
Other (OTH)
AF:
0.815
AC:
1720
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1087
2174
3260
4347
5434
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
872
1744
2616
3488
4360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.779
Hom.:
28582
Bravo
AF:
0.841
Asia WGS
AF:
0.856
AC:
2975
AN:
3478
EpiCase
AF:
0.764
EpiControl
AF:
0.775

Local populations

Turkish Variome
AF:
0.768
AC:
5162
AN:
6720
Hom.:
2001
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.902
AC:
8086
AN:
8960
Hom.:
3655
ABraOM SABE-WGS-1171
AF:
0.828
AC:
1938
AN:
2340
Hom.:
802

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (9)
-
-
5
Familial adenomatous polyposis 1 (6)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
3
not provided (3)
-
-
1
APC-Associated Polyposis Disorders (1)
-
-
1
Classic or attenuated familial adenomatous polyposis (1)
-
-
1
Familial multiple polyposis syndrome (1)
-
-
-
Familial colorectal cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.046
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
13
DANN
Benign
0.81
DEOGEN2
Benign
0.27
T
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.40
FATHMM_MKL
Benign
0.050
N
LIST_S2
Benign
0.11
T
MetaRNN
Benign
6.3e-7
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-0.90
N
PhyloP100
2.4
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
0.59
N
REVEL
Benign
0.19
Sift
Benign
0.67
T
Sift4G
Benign
0.082
T
Varity_R
0.084
gMVP
0.28
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs459552;
hg19: chr5-112176756;
COSMIC: COSV57321643;
COSMIC: COSV57321643;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.